# A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers

> **NCT01858545** · NA · TERMINATED · sponsor: **Integra LifeSciences Corporation** · enrollment: 56 (actual)

## Conditions studied

- Foot Ulcer, Diabetic

## Interventions

- **DEVICE:** MatriStem
- **DEVICE:** Cellular Dermal Replacement Tissue

## Key facts

- **NCT ID:** NCT01858545
- **Lead sponsor:** Integra LifeSciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-05
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2021-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01858545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01858545, "A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01858545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*